
Study published in the New England Journal of Medicine (NEJM) finds no significant difference in survival rates between cancer patients treated with Taxotere and those taking Taxol (generic: pacitaxel).
Study published in the New England Journal of Medicine (NEJM) finds no significant difference in survival rates between cancer patients treated with Taxotere and those taking Taxol (generic: pacitaxel).